News

Citi Reiterates Strong Buy Rating and Price Target for KeyCorp

Citi Reiterates Strong Buy Rating and Price Target for KeyCorp

Citi Reiterates Strong Buy Rating and Price Target for KeyCorp

Citi has reaffirmed its Buy rating for KeyCorp (NYSE: KEY), keeping a price target of $19.00 for this financial services company. This positive assessment follows the recent earnings report released by KeyCorp, which largely aligned with Citi's expectations for core pre-provision net revenue (PPNR).

Performance Analysis

In the earnings report, KeyCorp revealed some minor fluctuations in fees and expenses; however, these discrepancies were mostly balanced out. The management of KeyCorp has indicated an optimistic outlook for the fourth quarter, expecting a net interest income (NII) exit rate that exceeds $1,020 million. Although this projection falls slightly below the Visible Alpha consensus of $1,031 million, it still reflects a stable revenue outlook. Furthermore, the net interest margin (NIM) is anticipated to hover around 2.40%, showcasing the company's ongoing efficiency in managing its income source.

Charge-offs and Financial Ratios

During this quarter, KeyCorp noticed a slight uptick in net charge-offs (NCOs). The guidance set forth by management estimates the 2024 NCOs will stay within a range of 35-40 basis points. Interestingly, even with this slight increase, KeyCorp was able to release reserves during the quarter. The company has also seen an improvement in its Common Equity Tier 1 (CET1) ratio, which strengthened by 30 basis points to reach 10.8%, attributed to a 2% reduction in risk-weighted assets (RWAs).

Market Reactions and Ratings

KeyCorp has recently attracted the attention of several investment firms, underscoring the growing interest in its performance. Goldman Sachs has maintained a Buy rating on KeyCorp following the noteworthy third-quarter earnings report, which revealed a core earnings per share (EPS) of $0.30. This surpasses the anticipated figure of $0.28, a positive outcome attributed to the company managing its core expenses effectively.

Barclays has echoed this sentiment by retaining its Equalweight rating, pointing out that KeyCorp's EPS surpassed expectations primarily due to better-than-expected net interest income coupled with controlled spending. Conversely, Baird downgraded the stock from Outperform to Neutral and adjusted their price target downward from $18 to $17, citing the substantial increase in the company's share price as a concern moving forward.

Positive Outlook at Citi

Overall, Citi maintains a positive stance on KeyCorp, reiterating its Buy rating alongside the $19.00 price target for the company’s shares. Additionally, Citi has raised its EPS forecast for 2025, now expecting it to reach $1.55, indicating solid confidence in the bank's financial trajectory. Piper Sandler also expressed positivity, confirming an Overweight rating on KeyCorp with a consistent price target of $18.00, representing strong faith in the bank's future performance.

InvestingPro Insights

KeyCorp's performance, bolstered by Citi's optimistic outlook, is further validated with real-time insights revealing a price-to-earnings (P/E) ratio of 22.87. This metric illustrates that investors are inclined to pay a premium for KeyCorp’s earnings, reflecting their confidence in its potential for growth. This aligns seamlessly with Citi's Buy rating and set price target of $19.00.

Commitment to Shareholders

KeyCorp has a remarkable history of dividend payments, having sustained its dividends for 53 successive years. This dedication to shareholder returns is especially compelling considering the company’s current dividend yield of 4.63%, a rate that appeals strongly to income-driven investors. Moreover, KeyCorp has experienced a substantial increase in its share price, marked by a 25.95% total return over the past six months, as reported by InvestingPro.

Conclusion

These insights not only complement the earnings report discussed above but also provide a broader view of KeyCorp’s financial health and market standing. Investors seeking an in-depth understanding of the company’s position and future prospects will find that the current landscape presents several opportunities for engagement.

Frequently Asked Questions

What is Citi's rating on KeyCorp?

Citi has maintained a Buy rating on KeyCorp with a price target of $19.00.

How did KeyCorp perform in its recent earnings report?

KeyCorp's earnings report showed core pre-provision net revenue largely matching estimates, with a slight increase in core EPS to $0.30.

What are KeyCorp's projections for net interest income?

KeyCorp anticipates a net interest income exit rate exceeding $1,020 million for the fourth quarter.

How does KeyCorp's dividend yield compare?

KeyCorp currently offers a dividend yield of 4.63%, reflecting its robust commitment to shareholder returns.

What is KeyCorp's recent stock performance?

KeyCorp has seen a strong price uptick, with a 25.95% total return over the past six months.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 38

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Medline's MedTrans Rodeo: Honoring Driver Excellence

Updated Category News Views 72

Rollin' Down the Road of Excellence In the world of healthcare logistics, Medline's MedTrans team isn't just steering trucks—they're steering safety culture and supply chain efficiency. This October, they wrapped up their fourth annual National Truck Rodeo in Mundelein, Illinois. And let me tell you, it was more than just a fancy event. It was about celebrating the real...

Continue Reading
Quest Diagnostics Faces Class Action After Data Breach

Updated Category News Views 4

Data Breach Rocks Quest Diagnostics October 2026 caught Quest Diagnostics in a bind they wish they could escape—a classic tech breach with personal info hanging out to dry. When a cyber ghost slipped into Quest's Quanum Lab Services Manager, it wasn't to deliver flowers. Nope, this unauthorized access was no friendly visit, forcing Quest to scream foul and play serious...

Continue Reading
Think Together Marks 20 Years of ASES Impact in CA

Updated Category News Views 77

Hands-on Learning: California's Bright Future Starts Here Who's ever thought a schoolyard's the same after three? Let me tell you, in California, it's staying alive and kicking, thanks to Think Together's whirlwind of celebrations for the After School Education and Safety (ASES) program. We're talking 450 schoolyard shindigs highlighting not just how far expanded learning...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 146

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 35

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 150

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
Galien Recognizes Kerry for Transformative Global Health Work

Updated Category News Views 75

Kerry's Legacy: A Symbol of Global Unity In the ever-thickening jungle of geopolitics and global health, it's rare to find a beacon as steadfast as John Kerry. This year, The Galien Foundation saw fit to honor him with the 2026 Roy Vagelos Pro Bono Humanum Award for Global Health Equity. This ain't just some shiny trinket—it’s a testament to his lifetime of ripping...

Continue Reading
PZZA Faces Class Action: Strategic Shake-up or Misstep?

Updated Category News Views 10

Papa John's: Doughy Deceit or Strategic Misfire? Once in a while, a corporation trips over its own ambitious production line, and Papa John’s (NASDAQ:PZZA) is the latest contestant to make headlines for all the wrong reasons. Investors in this pizza powerhouse are being called to the courtroom as a class action lawsuit unfolds, marking a turbulent stage in the...

Continue Reading
Monterey Desalination Project: Costs, Challenges & Future

Updated Category News Views 19

Water Woes Dragging on in Monterey? Alright, let's dive into the nitty-gritty of this water supply saga in the Monterey Peninsula. If you're wondering why California American Water is hustling so hard, it's because the taps around here ain't running like they should. This mess has been stretching on for ages, with everyone thirsty for a sustainable answer. The Cost of...

Continue Reading

Top 5 Most Recently Viewed Articles

Axsome Therapeutics Reaches Settlement on Sunosi Patent Dispute

Updated Category News Views 100

Settlement Agreement Between Axsome Therapeutics and Hikma Axsome Therapeutics, Inc. (NASDAQ: AXSM), a forerunner in biopharmaceutical development, has recently announced a significant settlement agreement with Hikma Pharmaceuticals USA. This agreement resolves ongoing patent litigation concerning Sunosi (solriamfetol), Axsome's treatment for excessive daytime sleepiness....

Continue Reading
Cryptocurrency Market Stagnates as Analysts Forecast Drop

Updated Category News Views 174

Current Overview of Major Cryptocurrencies The leading cryptocurrencies are holding steady in their positions, with many traders observing a stable yet uneventful market environment. Recently, a feeling of optimism arose as stock markets showed signs of recovery amidst expectations of possible interest rate cuts in the near future. Market Status of Bitcoin and Ethereum...

Continue Reading
Discover the Meteor Profit App: Empower Your Trading Experience

Updated Category News Views 527

Revolutionizing Online Trading with Meteor Profit Meteor Profit has become a prominent name among investors seeking efficient and secure online trading platforms. This innovative tool connects users with licensed brokers, creating opportunities backed by advanced technology for users looking to maximize their trading experiences. What is Meteor Profit? Meteor Profit is a...

Continue Reading
Exciting Updates from Nasdaq Ahead of Q2 Financial Results

Updated Category News Views 125

Upcoming Nasdaq Investor Conference Call Nasdaq has set its sights on providing investors with critical insights into its financial performance for the second quarter of 2025. As one of the leading global technology firms operating in the capital markets, Nasdaq's updates are highly anticipated by stakeholders. Event Details Who Will Be Present: Nasdaq’s leadership...

Continue Reading
Smart for Life Faces Delisting from Nasdaq: A Challenging Journey

Updated Category News Views 136

Smart for Life's Delisting from Nasdaq: What You Need to Know Recently, Smart for Life, Inc. encountered a significant setback by being officially delisted from The Nasdaq Capital Market. This decision has raised concerns and initiated discussions about the company's adherence to important regulations and listing requirements. What Caused the Delisting? The delisting took...

Continue Reading